Method Principle
Membrane filtration sterility testing passes a liquid product sample through a membrane filter fine enough to retain any viable microorganisms present, then transfers that filter into growth media and incubates it, allowing any retained organism to grow into a detectable population over the incubation period. This approach is generally preferred over the alternative direct inoculation method wherever the product's own physical and chemical characteristics allow it, since filtration also physically removes any inherent antimicrobial activity in the product itself, avoiding a false-negative result caused by residual product antimicrobial activity suppressing organism growth in the test media. Membrane filtration therefore serves a dual role, both concentrating any organisms present onto a small, easily incubated filter surface and separating them from a product matrix that might otherwise interfere with reliable growth detection.
Sample Handling
Sterility testing must be performed under conditions that themselves introduce no extraneous contamination, typically within a Grade A environment such as an isolator or a validated laminar airflow cabinet, since the test's entire premise depends on any detected growth genuinely originating from the sample itself rather than from the testing process or environment. Sample size and the number of units tested are defined by compendial requirements based on batch size, and samples should be selected to represent the batch appropriately, including units from throughout the manufacturing and filling run rather than exclusively from a single, convenient point in that run.
Incubation and Reading
Following filtration, membrane portions are incubated in two media, not one general-aerobic and one general-anaerobic split: Fluid Thioglycollate Medium (FTM), incubated at 30–35°C, supports both anaerobic and aerobic bacteria; Soybean-Casein Digest Medium (SCDM/TSB), incubated at 20–25°C, supports aerobic bacteria, yeasts and molds. The two media overlap on aerobic bacteria, which is deliberate: it is the combination that gives broad, complementary recovery, not a strict aerobic/anaerobic division between them. Reading, visual or, increasingly, automated turbidity-based, is performed at defined intervals over the incubation period to detect any developing growth. Growth promotion testing (GPT) confirms a given media lot can reliably support growth of a defined panel of representative challenge organisms; it is performed for each lot of media before or in parallel with its use, not repeated as a fresh control on every individual test run performed with an already-qualified lot. A media lot that fails GPT cannot be used, since it could produce a falsely reassuring negative result regardless of whether the tested sample was actually sterile.
Negative controls (uninoculated medium, confirming the testing environment and process introduce no extraneous contamination of their own) are run alongside every test. Growth in a negative control is one of several defined conditions under which a test may be considered invalid — the others being a documented fault found in the testing facility's own environmental monitoring data, a fault found on review of the testing procedure, or microorganisms isolated from the test that can, after identification, be unequivocally ascribed to a fault in the test material or technique. Invalidation is a conclusion an investigation reaches after reviewing the relevant evidence against these conditions, documented with its supporting rationale — not an automatic reflex triggered by observing any growth anywhere in the run. A negative control failure does not, by itself, excuse a positive result in the test article unless the investigation specifically and credibly connects the two; each result is evaluated on the evidence that actually explains it. Once a test is genuinely found invalid, it is repeated using the same number of units as the original test.
Result Interpretation
A sterility test showing no growth across the incubation period supports, but importantly does not alone conclusively prove, that the tested batch is genuinely sterile, since sterility testing samples only a small fraction of the total batch and carries well-recognized statistical limitations in its ability to detect low-level or non-uniformly distributed contamination. This is precisely why sterility test results are interpreted alongside the broader body of manufacturing evidence, including environmental monitoring and personnel monitoring data from the actual manufacturing session, rather than treated as a standalone, sufficient determination of batch sterility on their own.
Handling a Positive Sterility Result
Where growth is observed, investigation must first determine whether the growth genuinely originated from the sample or from a laboratory testing artifact, following structured investigation principles similar to those applied to any OOS result, examining the testing environment, negative control performance, and organism identification, since the specific organism identified can itself provide important clues about whether contamination is more consistent with a genuine product sterility failure or a laboratory-introduced artifact. A positive result not clearly and specifically attributable to laboratory error must be treated as a genuine sterility failure, triggering batch rejection and a broader investigation into the manufacturing process that produced the affected batch.
Relationship to Aseptic Process Controls
Sterility testing functions as one layer within a much broader sterility assurance strategy for aseptically manufactured products, complementing rather than substituting for environmental monitoring, personnel monitoring, and process simulation studies, given the statistical sampling limitations inherent to sterility testing discussed above. A facility relying primarily on sterility testing itself as its main sterility assurance mechanism, rather than treating it as one component within this broader, multi-layered control strategy, is relying on a considerably weaker overall assurance approach than one built around comprehensive, prevention-focused aseptic process control.
Method Suitability for Sterility Testing
As with microbial limit testing, sterility test method suitability must be confirmed for each specific product, verifying the product itself, once filtered and rinsed according to the validated procedure, does not carry through inhibitory residual antimicrobial activity capable of suppressing genuine microbial growth during incubation. This method suitability work, including determining appropriate rinse volumes and confirming their adequacy specifically for the product in question, should be completed and documented before the method is relied upon for routine batch release testing.
Leave your rating